In view of the recent findings that specific inhibition of GM-CSF has beneficial effects in RA patients (11–14), our study identified a unique circulating population of GM-CSF secreting peripheral T and B lymphocytes that could participate in the inflammatory process that characterizes RA. The gene discussed is CSF2; the disease is rheumatoid arthritis.